2m 2m 2m 2m 2m 2m 2m
DESIGN THERAP (DSGN)
NASDAQ
$10.44+$0.27 (+2.61%)
Price as of Jun 03, 2026 4:10 PM EDT- $654.5MMarket Cap
- 153.62%1-Year Change
- BiotechnologyIndustry
DESIGN THERAP (DSGN)
$10.44+$0.27 (+2.61%)
DSGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.17 | ||
Change | -$0.27 (-2.59%) | ||
Open | $10.30 | ||
High | $10.39 | ||
Low | $9.87 | ||
Previous Close | $10.44 | ||
Volume | 1,052,678 | ||
30-Day Average Volume | 1,273,918 | ||
1-Week Change | -10.79% | ||
1-Month Change | -23.53% | ||
1-Year Change | 153.62% | ||
3-Year Change | 76.56% | ||
5-Year Change | -61.26% | ||
Fundamentals | |||
Shares Outstanding | 62.5M | ||
Total Assets | $230.4M | ||
Market Cap | $654.5M | ||
Enterprise Value | $641.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$16.4M | ||
EBIT | -$17.6M | ||
EBITDA | -$17.5M | ||
Net Working Capital | $216.9M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -36 | ||
PEG | 6 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue